Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1977 January; 70(1): 4–15.
PMCID: PMC1542902

Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Awaness AM, Mitchison DA. Cumulative effects of pulsed exposures of mycobacterium tuberculosis to isoniazid. Tubercle. 1973 Jun;54(2):153–158. [PubMed]
  • Bailey WC, Thompson DH, Jacobs S, Ziskind M, Greenberg HB. Evaluating the need for periodic recall and re-examination of patients with inactive pulmonary tuberculosis. Am Rev Respir Dis. 1973 May;107(5):854–857. [PubMed]
  • Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41(1):21–43. [PubMed]
  • Chmelev NA, Alyabina MG. Collective studies from the whole of the Soviet Union on controlled chemotherapy of pulmonary tuberculosis. Bull Int Union Tuberc. 1972 Feb;47:22–29. [PubMed]
  • Dawson JJ, Devadatta S, Fox W, Radhakrishna S, Ramakrishnan CV, Somasundaram PR, Stott H, Tripathy SP, Velu S. A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS. Bull World Health Organ. 1966;34(4):533–551. [PubMed]
  • DEVADATTA S, ANDREWS RH, ANGEL JH, BHATIA AL, FOX W, JANARDHANAM B, RADHAKRISHNA S, RAMAKRISHNAN CV, SUBBAIAH TV, VELU S. Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate. Bull World Health Organ. 1961;24:149–175. [PubMed]
  • Dickinson JM, Jackett PS, Mitchison DA. The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis. Am Rev Respir Dis. 1972 Apr;105(4):519–527. [PubMed]
  • Dickinson JM, Mitchison DA. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis. Tubercle. 1970 Mar;51(1):82–94. [PubMed]
  • Evans C, Devadatta S, Fox W, Gangadharam PR, Menon NK, Ramakrishnan CV, Sivasubramanian S, Somasundaram PR, Stott H, Velu S. A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone. Bull World Health Organ. 1969;41(1):1–16. [PubMed]
  • Fox W, Mitchison DA. Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis. 1975 Mar;111(3):325–353. [PubMed]
  • GANGADHARAM PR, DEVADATTA S, FOX W, NAIR CN, SELKON JB. Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS. Bull World Health Organ. 1961;25:793–806. [PubMed]
  • Heffernan JF, Nunn AJ, Peto J, Fox W. Tuberculosis in Scotland: a national sample survey (1968-70). 2. A two-year follow-up of newly-diagnosed respiratory tuberculosis notified in 1968. Tubercle. 1976 Sep;57(3):161–175. [PubMed]
  • Johnston RF, Wildrick KH. The impact of chemotherapy on the care of patients with tuberculosis. Am Rev Respir Dis. 1974 Jun;109(6):636–664. [PubMed]
  • McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med. 1966 Mar 1;123(3):445–468. [PMC free article] [PubMed]
  • McDERMOTT W, ORMOND L, MUSCHENHEIM C, DEUSCHLE K, McCUNE RM, Jr, TOMPSETT R. Pyrazinamide-isoniazid in tuberculosis. Am Rev Tuberc. 1954 Mar;69(3):319–333. [PubMed]
  • MITCHISON DA. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT. Br Med J. 1965 May 22;1(5446):1333–1340. [PMC free article] [PubMed]
  • Mitchison DA, Dickinson JM. Laboratory aspects of intermittent drug therapy. Postgrad Med J. 1971 Nov;47(553):737–741. [PMC free article] [PubMed]
  • Owen D. Clinical freedom and professional freedom. Lancet. 1976 May 8;1(7967):1006–1009. [PubMed]
  • Pearce SJ, Horne NW. Follow-up of patients with pulmonary tuberculosis adequately treated by chemotherapy: is this really necessary? Lancet. 1974 Sep 14;2(7881):641–643. [PubMed]
  • RAMAKRISHNAN CV, RAJENDRAN K, JACOB PG, FOX W, RADHAKRISHNA S. The role of diet in the treatment of pulmonary tuberculosis. An evaluation in a controlled chemotherapy study in home and sanatorium patients in South India. Bull World Health Organ. 1961;25:339–359. [PubMed]
  • Ramakrishnan CV, Rajendran K, Mohan K, Fox W, Radhakrishna S. The diet, physical activity and accommodation of patients with quiescent pulmonary tuberculosis in a poor South Indian community. A four-year follow-up study. Bull World Health Organ. 1966;34(4):553–571. [PubMed]
  • Reichman LB. Routine follow-up of inactive tuberculosis: a practice that has been abandoned. Am Rev Respir Dis. 1973 Dec;108(6):1442–1443. [PubMed]
  • Sunahara S. A study of ethambutol as a supplement to standard triple-drug regimen. Bull Int Union Tuberc. 1970 Jun;43:316–321. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press